First National Trust’s Novartis NVS Stock Holding History

First National Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,691	Closed	-$222K	–	307
2015 Q3	$222K	Sell	2,691 -230	-8%	-$20.5K	0.04%	265
2015 Q2	$258K	Buy	2,921 +39	+1%	+$3.58K	0.04%	251
2015 Q1	$255K	Buy	2,882 +216	+8%	+$19.2K	0.04%	238
2014 Q4	$221K	Sell	2,666 -226	-8%	-$18.7K	0.04%	228
2014 Q3	$244K	Sell	2,892 -713	-20%	-$57.7K	0.05%	226
2014 Q2	$293K	Buy	+3,605	New	+$284K	0.06%	212

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

First National Trust's NVS Position: Q4 2015 in Review

First National Trust sold out of Novartis (NVS) in Q4 2015, closing a stake of 2,691 shares — an estimated $222K sold.

First National Trust first reported a position in NVS in Q2 2014 and held it in 6 quarters. The position peaked at $293K in Q2 2014. 926 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

First National Trust reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
First National Trust sold 2,691 Novartis shares in Q4 2015, an estimated $222K.
First National Trust first reported a position in Novartis in Q2 2014 and held it in 6 quarters.
First National Trust's Novartis position peaked at $293K in Q2 2014.
926 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on First National Trust's 13F filing for Q4 2015, filed 3 Feb 2016.